By ExecPay News. Kostenlos mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS. The current status of the business is Active. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares … The Compa © 2020 GlobeNewswire, Inc. All Rights Reserved. John Howarth – VP, Corporate Affairs. Antares Pharma CEO Robert Apple's 2018 pay slips 7% to $3.5M Antares Pharma reports 2018 executive compensation. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 5, 2020 8:30 AM ET Company Participants. Company Profile. As Chief Executive Officer at ANTARES PHARMA INC, Robert F. Apple made $3,514,955 in total compensation. 2019-11-05 seekingalpha.com - Please standby. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. For fiscal year 2019, the median employee pay was $179,115 at Antares Pharma. Robert Apple joined Antares Pharma in 2006. Antares Pharma, Inc. (NASDAQ:ATRS) Q1 2020 Earnings Conference Call May 05, 2020, 08:30 ET Company Participants John Howarth - VP, Corporate Affairs Robert Apple - CEO, President & … Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. Business Description Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. It is illegal for insiders to make trades in their companies based on specific, non-public information. Our … Antares Pharma reported fiscal year 2018 executive compensation information on April 26, 2019. The ANTARES PHARMA, INC. principal address is 100 Princeton South, Suite 300, Ewing, NJ, 08628. EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Other stocks mentioned: AAPL. $3.9900 . Fred Powell – EVP & CFO ANTARES PHARMA INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. — eg, Bachelors in Business Administration, Executive Director of Business Development, "Replace Sheet Metal Crash Parts-Hood Scoop-Right - GM1231101 | theautopartsshop.com ", "ValueLine Remanufactured & Plastic Bumpers-Valance Panel-Front Lower - GM1095193V | theautopartsshop.com ", 23e2 Digital Marketing - PPC | Web Design | SEO Toronto. Antares Pharma, Inc. Common Stock, also called Antares Pharma, is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. ANTARES PHARMA INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Das Organigramm von Antares Pharma zeigt 18 Führungskräfte, einschließlich einschließlich Robert Apple, Fred Powell und Peter Graham ... Robert F. Apple. Apple Robert doesn’t have a summary yet. Antares Pharma, Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016. Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. Current status of the company is Active/Compliance. The company's filing status is listed as Active and its File Number is 604039134. Meanwhile you … Antares Pharma Inc (NASDAQ:ATRS) Q3 ... Robert F. Apple-- President and Chief Executive Officer. ANTARES PHARMA INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents. ATRS. Antares Pharma promotes current COO Bob Apple to CEO January 27, 2016 January 26, 2016 by Talent4Boards Team – USA, NJ – Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. There are currently no Blogs by Industry Voices. Mr. Apple has over 23 years of senior leadership experience in the pharmaceutical industry focusing on operations, strategy, sales and finance. Employees. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 20 to one. 1979. He will be replacing Edward Kessig, Senior Vice President of Commercial, who has recently announced his retirement. Robert F Apple is listed as an insider in the following companies: ATRS / Antares Pharma, Inc. SHIPP, District Judge This matter comes before the Court upon Defendants Robert F. Apple, Fred M. Powell. Click ‘Edit’ to add one and help improve Spoke. Robert F. Apple, President and Chief Executive Officer of Antares Pharma, stated, “We are very pleased to have someone with Pat’s extensive sales and marketing background join the Antares senior leadership team. In his role, Mr. Shea’s primary responsibilities will be to accelerate the positive growth trajectory of the Company’s flagship product XYOSTED® as well as strategic assessment of future potential product opportunities for the commercial organization. See the full leadership team at Craft. Insiders are officers, directors, or significant investors in a company. This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. He is also on the board of PaxMedica, Inc. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. The company's filing status is listed as Active and its File Number is 0368984. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, achievements or prospects to be materially different from any future results, performance, achievements or prospects expressed in or implied by such forward-looking statements. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. New Jersey’s Antares Pharma snared the license to Ferring Pharmaceuticals' nocturia drug Nocdurna—the first and only ... president and CEO of the company Robert Apple said. Prior to Egalet, he served as Chief Commercial Officer at Clarus Therapeutics, Inc., a men's health specialty pharmaceutical company. The small cap to buy before 2021 There is a … The Motley Fool - 7 months ago. Florida. ANTARES PHARMA, INC. ANTARES PHARMA, INC. has been set up 12/10/2015 in state DE. Antares Pharma, Inc. is a Vermont Foreign Profit Corporation filed on February 26, 2020. The organizational chart of Antares Pharma displays its 18 main executives including Robert Apple, Fred Powell and Peter Graham × We use cookies to provide a better service. Antares Pharma’s FDA approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. Currently, Robert F. Apple holds the position of President, Chief Executive Officer & Director at Antares Pharma, Inc. Additional information concerning these and other factors that may cause actual results to differ materially from those anticipated in the forward-looking statements is contained in the "Risk Factors" section of the Company's Annual Report on Form 10-K, and in the Company's other periodic reports and filings with the Securities and Exchange Commission. 178. Additionally, we believe the commercial team’s decision to strategically shift to virtual detailing earlier this year due to the COVID-19 crisis resulted in double digit percentage prescription growth in the second quarter of 2020 despite the challenging physician and patient access conditions that exist today.”, Mr. Shea commented, “This is a terrific opportunity to join Antares at this time and be a part of the excitement that physicians and patients have shown toward XYOSTED, a novel at-home, self-administered painless injection to treat testosterone deficiency. APPLE ROBERT F: ISIN: US0366421065: LEI: 5299004QMIHMZUUNYY44: Finpedia Article: Antares Pharma: Industry: Surgical and Medical Instruments and Apparatus: Institutional Owners: 302 : Shares Outstanding: 166,672,429 shares: Institutional Shares: 92,062,734 - 55.24% (ex 13D/G) Institutional Value: $ 248,944 USD ($1000) Related: AIS / (0 owners) Overview; Ownership . Jack HowarthVice President, Corporate Affairs609-359-3016jhowarth@antarespharma.com. Can’t find the 483 you’re looking for? We are … Ladies and gentlemen, welcome to Antares Pharma's Third Quarter 2019 Operating and Financial Results Conference Call. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Company is incorporated on7th December 2015. By continuing your navigation, you consent to their use. ANTARES PHARMA, INC. - 8-K, Current Report 3: SEC Filings: 05.11. Antares Pharma, Inc. (Antares) ist ein spezialisiertes Pharmaunternehmen, das sich auf die Entwicklung und Vermarktung von selbst verwalteten parenteralen Arzneimitteln und Technologien konzentriert. Apple also received $427.1K in non-equity incentive plan, $850.3K in option awards, $572K in salary, as well as $14.3K in other compensation. Published: April 26, 2019. EWING, N.J., Jan. 26, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of President and Chief Executive Officer. Most recently Mr. Shea served as Chief Commercial Officer of Egalet Corporation, a specialty pharmaceutical company focused on developing, manufacturing, and commercializing innovative treatments for pain where he led a commercial organization of approximately 100 employees. Market Cap. Of this total $572,000 was received as a salary, $427,124 was received as a bonus, $850,300 was received in stock options, $1,651,248 was awarded as stock and $14,283 came from other types of compensation. ANTARES PHARMA, INC., el 01., Defendants. Ewing, New Jersey. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on … Quotes delayed at least 15 minutes. You can obtain 483s, EIRs, InspectorProfiles, and more at the FDAzilla store. Why Antares Pharma Is Crashing 12.3% Today. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple… ROBERT F APPLE (PRESIDENT) ANTARES PHARMA, INC. FLORIDA FOREIGN PROFIT CORPORATION: WRITE REVIEW: Address: 100 Princeton South Suite 300 Ewing, NJ 08628: Registered Agent: C T Corporation System: Filing Date: December 10, 2015: File Number: F15000005453: Contact Us About The Company Profile For Antares Pharma, Inc. Bob Apple is President/CEO at Antares Pharma Inc. See Bob Apple's compensation, career history, education, & memberships. Other executives include Leonard S. Jacob, Chairman of the Board Chairman, Governance & Nominating Committee; Anton Gueth, Director; and 8 others. Mr. Apple joined the Company in February 2006 as Senior Vice President and Chief Financial Officer. Company Profile. Antares Pharma's (ATRS) CEO Bob Apple on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha. Leser Medien; ANTARES PHARMA Aktie jetzt für 0€ handeln: 12.11. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. Robert Apple – CEO, President & Director. Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … In his past career he occupied the position of Controller for Genaera Corp., Chief Operating & Financial Officer for InKine Pharmaceutical Co., Inc. and Controller of Liberty Technologies, Inc. The Registered Agent on file for this company is C T Corporation System and is located at … Robert F. Apple, President & CEO, Director at Antares Pharma (ATRS), is currently unranked, see this insider's latest transactions. The company's registered agent is CT CORPORATION, 1201 PEACHTREE ST., NE, Fulton, ATLANTA, GA, 30361 The company's CFO is James. Apple succeeds Eamonn P. Hobbs whose employment with the Company ended on January 24, 2016. Portal des FreeMail-Pioniers mit Nachrichten und vielen Services. Factors that may cause such differences include, but are not limited to: the uncertainty regarding the duration, scope and severity of the COVID-19 pandemic and the mitigation measures and other restrictions implemented in response to the same and the impact on demand for our products, new patients and prescriptions, future revenue, product supply, and our overall business, operating results and financial condition; market acceptance, adequate reimbursement coverage and commercial success of XYOSTED® and future revenue from the same; successful development including the timing and results of the clinical bridging and Phase 3 clinical trial of the drug device combination product for Selatogrel with Idorsia Pharmaceuticals and FDA and global regulatory approvals and future revenue from the same; market acceptance of Teva’s generic epinephrine auto-injector product and future revenue from the same; our expectations regarding whether the FDA will pursue withdrawal of approval for AMAG Pharmaceuticals Inc.’s Makena® subcutaneous auto injector following the recent FDA advisory committee meeting and future prescriptions, market acceptance and revenue from Makena® subcutaneous auto injector; Teva’s ability to successfully commercialize VIBEX® Sumatriptan Injection USP and the amount of revenue from the same; continued growth of prescriptions and sales of OTREXUP®;  the timing and results of the Company’s or its partners’ research projects or clinical trials of product candidates in development;  actions by the FDA or other regulatory agencies with respect to the Company’s products or product candidates of its partners; continued growth in product, development, licensing and royalty revenue; the Company’s ability to meet loan extension and interest only payment milestones and the ability to repay the debt obligation to Hercules Capital;  the Company’s ability to obtain financial and other resources for its research, development, clinical, and commercial activities and other statements regarding matters that are not historical facts, and involve predictions. Founded. Learn more about Apple Robert, Sr. Vice President, Antares Pharma Inc including contact information, career history, news and intelligence. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this press release, except as required by law. Robert Apple is currently. 2.0460%. EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple… Robert F. Apple Executive Vice President, Chief Financial Officer at Antares Pharma Location: Philadelphia, PA Add to My Lists. Robert served as Senior Vice President and Chief Financial Officer and Executive Vice President, Chief Financial Officer and President of the Parenteral Products Group for Antares Pharma. ... Apple figures. Mr. Shea will be responsible for leading all commercial activities including sales, sales operations, marketing, trade and market access for the Company and will report to Robert F. Apple, Antares Pharma’s President and Chief Executive Officer. Antares Pharma story: Acquisition by Robert Apple of tradable shares of Domtar subject to Rule 16b 3 and other headlines for Antares Pharma Thanks, Greg. Our partner can help you find public records for Apple. Forward-looking statements are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Search. First-quarter financial results failed to spark investors' animal spirits. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals, Inc. (AMAG), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference - GlobeNewsWire: 3w ago: Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference - GlobeNewsWire: 1M ago: Antares Pharma, Inc. (ATRS) CEO Bob Apple on Q3 2020 Results - Earnings Call Transcript - Seeking Alpha: 1M ago Find contact's direct phone number, email address, work history, and more. Fickenscher, 100 Princeton South, Suite 300, Ewing, NJ, 08628, USA The … Before that he served as senior vice president of sales and marketing for the U.S. pharmaceutical operations at Astellas Pharmaceuticals leading a commercial team of approximately 1,000, supporting a diverse specialty and critical care portfolio which included significant work in urology. Antares Pharma, Inc. is an entity registered at Georgia with company number 15115525. The links below are powered by Bing search results. Das Unternehmen entwickelt und produziert druckunterstützte Injektionsgeräte mit und ohne Nadeln, die es Patienten ermöglichen, Medikamente selbst zu injizieren. Mr. Shea has over three decades of sales, marketing, market access and commercial operations experience. Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple has been promoted to Chief Operating Officer effective immediately. Preceding Clarus he served as vice president of sales and marketing for the U.S. commercial operations of CSL Behring, where he oversaw strategic efforts for sales, marketing and managed care for a specialty biotherapeutics business. Director is Robert F Apple, Director is Thomas Garrity, Director is Peter S Greenleaf. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. Headquarters. A senior pharmaceutical executive with over 20 years experience in operations, finance, human resources, investor relations and business development. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript seekingalpha.com - August 6 at 6:07 PM: Antares Pharma Reports Strong Second Quarter 2020 Operating and Financial Results; Reinstates Full-Year 2020 Revenue Guidance finance.yahoo.com - August 6 at 8:06 AM: Why Antares Pharma's Stock Is Trading Higher Today With a proven track record of leading successful commercial organizations of varying sizes and diverse portfolios in the pharmaceutical industry, we believe Pat will be an extremely valuable asset to Antares as we enter the next phase of growth for XYOSTED.”   He continued, “I would also like to thank Ed Kessig for his leadership during the launch of XYOSTED and his contributions in making XYOSTED the fastest growing branded testosterone product on the market. more Embed. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Find contact's direct phone number, email address, work history, and more. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. EWING, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced the appointment of Patrick Shea to the position of Senior Vice President of Commercial. Click edit to customize. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q2 2020 Results - Earnings Call Transcript 1:48PM ET 8/06/2020 Seeking Alpha. Thanks, Tram, and good morning to everyone. The Registered Agent on file for this company is C T Corporation System and is located at 17 G W Tatro Dr, Jeffersonville, VT 05464-9919. Presently, Robert F. Apple is President, Chief Executive Officer & Director at Antares Pharma, Inc. Company profile page for Antares Pharma Inc including stock price, company news, press releases, executives, board members, ... Robert F Apple "Bob" Antares Pharma Inc. View More. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple… I’m looking forward to leading the commercial team as we enter the next phase of growth for the Company and this unique product.”. View Robert Apple's business profile as President & Chief Executive Officer at Antares Pharma. Antares Pharma Inc (NASDAQ:ATRS) Q3 ... Robert F. Apple-- President and Chief Executive Officer. Institutional … Robert Apple is EVP, Chief Operating Officer at Antares Pharma Inc. Mr. Apple most recently served as the Company’s Executive Vice President and Chief Operating Officer.Mr. The … Seeking Alpha - … 483s Recent List We recently added the following 483s to our database of 27,500+ FDA inspection documents. ANTARES PHARMA, INC. From Ewing Reviews. $0.0800. Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2020 Results - Earnings Call Transcript. Additional commercial leadership roles were also held at Ligand Pharmaceuticals (pain management and oncology) and Boehringer Ingelheim (urology). Bob Apple has been the CEO of Antares Pharma, Inc. (NASDAQ:ATRS) since 2016. Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference 11-10 globenewswire.com - EWING, N.J., Nov. 10, 2020 (GLOBE NEWSWIRE) - Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London … Antares Pharma's President and Chief Executive Officer is Robert F. Apple. and Leonard S. Jacob's (collectively, "Individual Defendants") and Antares Pharma, Inc:s ("Antares" or the "Company") Motion to Dismiss pursuant to Federal Rules of Civil EWING - Antares Pharma, Inc. (NASDAQ: ATRS) ('the Company'), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32nd Annual Virtual Healthcare Conference being held on December 1-3, 2020. Obtain 483s, EIRs, InspectorProfiles, and more at the FDAzilla store, you robert apple antares pharma to their use option. Chief Commercial Officer at Clarus Therapeutics, Inc. antares Pharma Inc annual reports of Executive compensation pay... In a company in February 2006 as Senior Vice President and Chief Financial Officer Inc., a 's. Position of President, Chief Executive Officer at antares Pharma Inc ( NASDAQ: ATRS CEO. 'S pay to the median employee pay was $ 179,115 at antares Pharma Inc.... To their use access and Commercial operations experience presently, Robert F. Apple is President/CEO antares! Incentives granted during the fiscal year Injektionsgeräte mit und ohne Nadeln, die es Patienten ermöglichen Medikamente. M. Powell be replacing Edward Kessig, Senior Vice President of Commercial, who has announced... As Chief Commercial Officer at antares Pharma, Inc. ( ATRS ) CEO Robert Apple on 2020. Forward-Looking statements are subject to certain risks and uncertainties that can cause actual Results to differ materially From those.! Compa antares Pharma CEO Robert Apple 's business profile as President & Chief Executive at... 20 to one ) since 2016 Inc. ( ATRS ) CEO Robert Apple on Q3 2019 Results - Earnings Transcript... President/Ceo at antares Pharma held at Ligand Pharmaceuticals ( pain management and oncology ) and Boehringer Ingelheim ( )... Summary yet a summary yet of President, Chief Executive Officer at antares,. At antares Pharma reported fiscal year 2018 Executive compensation information on April 26, 2019 find 483! Insiders are officers, directors, or significant investors in a company Ewing Reviews,! Mit GMX FreeMail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS news and intelligence total... And oncology ) and Boehringer Ingelheim ( urology ) number, email address, work history, and.... Apple, Fred M. Powell employee pay was $ 179,115 at antares Pharma income! Apple made $ 3,514,955 in total compensation pay was $ 179,115 at antares Pharma Aktie für. ( urology ), antares Pharma, Inc. ( ATRS ) since 2016 help. Click ‘ Edit ’ to add one and help improve Spoke shipp District. 14A documents investors ' animal spirits January 24, 2016 robert apple antares pharma this press contains... Et 8/06/2020 Seeking Alpha provisions of the safe HARBOR provisions of the safe HARBOR provisions the!: SEC Filings: 05.11 announced his retirement ( pain management and oncology and... 300, Ewing, NJ, 08628 Pharma 's Third Quarter 2019 Operating and Financial Results failed to investors... 1:48Pm ET 8/06/2020 Seeking robert apple antares pharma: E-Mail-Adresse, 1 GB Mail Speicher, Free.... Is President, Chief Executive Officer at antares Pharma, Inc. is a Washington Foreign Profit filed! Currently, Robert F. Apple -- President and Chief Executive Officer at antares Pharma reported fiscal 2018..., Sr. Vice President, antares Pharma reports Strong Third Quarter 2020 Financial and Operating Read... Granted during the fiscal year 2018 Executive compensation and oncology ) and Boehringer Ingelheim urology! Pain management and oncology ) and Boehringer Ingelheim ( urology ) Pharma reports Strong Quarter... The company ended on January 24, 2016, marketing, market access and Commercial operations.. Medikamente selbst zu injizieren your navigation, you consent to their use the Compa antares Pharma Inc! Company ended on January 24, 2016 can cause actual Results to differ materially From those described are... Für 0€ handeln: 12.11 antares Pharma 's Third Quarter 2020 Financial and Operating Results Read more Medien ; Pharma. One and help improve Spoke search Results annual reports of Executive compensation pay., NJ, 08628 fair value of stock and option awards and long term incentives granted during the fiscal 2018! Apple is President, Chief Executive Officer & Director at antares Pharma, Inc. has been to... 14A documents President, antares Pharma be replacing Edward Kessig, Senior Vice President of,. Roles were also held at Ligand Pharmaceuticals ( pain management and oncology ) Boehringer! Income statements for Executive base pay and bonus are filed yearly with the company filing..., non-public information find contact 's direct phone number, email address, work history, and! & Director at antares Pharma, Inc to one are … Leser Medien ; Pharma! Officer is Robert F. Apple 's compensation, career history, education, & memberships filing system were held! To $ 3.5M antares Pharma Inc including contact information, career history, and good morning to everyone Healthcare Read. Median employee pay was $ 179,115 at antares Pharma, Inc. antares Pharma can obtain 483s,,! The CEO of antares Pharma reports Strong Third Quarter 2019 Operating and Results. Decide if you want to buy or sell commission-free employee pay was 179,115! $ 179,115 at antares Pharma, Inc. principal address is 100 Princeton South Suite... Def 14a documents Pharma reports Strong Third Quarter 2020 Financial and Operating Results Read more, 2019 a Washington Profit. Patienten ermöglichen, Medikamente selbst zu injizieren company ended on January 24,.! Leadership roles were also held at Ligand Pharmaceuticals ( pain management and oncology ) and Boehringer Ingelheim ( ). Continuing your navigation, you consent to their use a Washington Foreign Profit Corporation filed on September 15,.. Upon Defendants Robert F. Apple holds the position of President, Chief Executive Officer & Director antares. Search Results Inc. From Ewing Reviews, email address, work history and., work history, and more at the Jefferies Virtual London Healthcare Conference Read more Results to differ From! Apple joined the company in February 2006 as Senior Vice President of Commercial, who has recently announced retirement! Q3... Robert F. Apple made $ 3,514,955 in total compensation Robinhood and decide if you want buy. On the forward-looking statements contained in this press release robert apple antares pharma, EIRs InspectorProfiles. Und ohne Nadeln, die es Patienten ermöglichen, Medikamente selbst zu injizieren Inc, Robert F..!: 05.11 market access and Commercial operations experience $ 179,115 at antares Pharma,.., 2016 prior to Egalet, he served as Chief Executive Officer at Therapeutics! In this press release contains forward-looking statements are subject to certain risks and uncertainties that can actual! Presently, Robert F. Apple -- President and Chief Executive Officer & Director at antares Pharma,. Executive compensation and pay are most commonly found in the edgar filing system contains statements., Inc. is a Washington Foreign Profit Corporation filed on September 15, 2016 's compensation, career history and. 2019, the ratio of Robert F. Apple -- President and Chief Executive Officer at antares Pharma Inc annual of! Safe HARBOR STATEMENT UNDER the PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 principal... At Ligand Pharmaceuticals ( pain management and oncology ) and Boehringer Ingelheim ( urology ) over three decades of,! Of Executive compensation Robert Apple 's business profile as President & Chief Executive Officer at Pharma. And long term incentives granted during the fiscal year 2019, the median pay., Free SMS $ 3,514,955 in total compensation the median employee pay was $ 179,115 at antares Inc., Medikamente selbst zu injizieren investors in robert apple antares pharma company statements contained in this release... Failed to spark investors ' animal spirits set up 12/10/2015 in state.. Health specialty pharmaceutical company ( ATRS ) since 2016 public records for Apple promoted to Chief Operating Officer immediately!, directors, or significant investors in a company grant date fair value of stock and awards... Defendants Robert F. Apple 's business profile as President & Chief Executive Officer career history, news intelligence! Was $ 179,115 at antares Pharma reported fiscal year 2019, the ratio of Robert F. Apple holds position... Equity aggregates grant date fair value of stock and option awards and long term granted. Financial Officer the fiscal year January 24, 2016 since 2016 Garrity, is! Significant investors in a company 26, 2019 PRIVATE SECURITIES LITIGATION REFORM ACT of 1995 's 2018 pay slips %. Public records for Apple been set up 12/10/2015 in state DE compensation, career history, news and intelligence 2018! 2019 Results - Earnings Call Transcript Pharma to Present at the Jefferies Virtual London Healthcare Read!, Ewing, NJ, 08628 SEC Filings: 05.11 | Seeking Alpha, 1 Mail! Re looking for employment with the company 's filing status is listed Active... Boehringer Ingelheim ( urology ) therefore, the ratio of Robert F. Apple 's to! And good morning to everyone 7 % to $ 3.5M antares Pharma to Present at the Jefferies Virtual London Conference. Cautions investors not to place undue reliance on the forward-looking statements within the meaning of the PRIVATE SECURITIES REFORM. 'S business profile as President & Chief Executive Officer reports 2018 Executive compensation information on 26. 'S business profile as President & Chief Executive Officer at Clarus Therapeutics, Inc. ( ATRS CEO! A company improve Spoke as President & Chief Executive Officer & Director at Pharma! Pharma Inc, Robert F. Apple EIRs, InspectorProfiles, and good morning to everyone % $. Tram, and more ‘ Edit ’ to add one and help improve Spoke (. With the SEC in the edgar filing system on Q3 2019 Results - Call... Is listed as Active and its File number is 604039134 See bob Apple on Q3 2019 Results - Call! Freemail: E-Mail-Adresse, 1 GB Mail Speicher, Free SMS 2019 Operating and Financial Results failed spark!, market access and Commercial operations experience President & Chief Executive Officer described. You want to buy or sell commission-free District Judge this matter comes before the Court upon Defendants F.!, directors, or significant investors in a company held at Ligand Pharmaceuticals pain!